WEEKLY SCAN | July 22, 2018
This has been an unusually slow summer week. Five documents published by FDA, three of which address user fees for FY2019 for Generic drugs, devices and food re-inspections, one from EMA and two each from WHO and TGA. Non-guidance publications were issued by FDA, EMA, MHRA ICH and HPRA. Enforcement was very slow with one warning letter issued to [...]